Literature DB >> 25936385

Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment.

Yeşim Akkoç1, Murat Ersöz2, Nur Yüceyar3, Hakan Tunç2, Kurtuluş Köklü2, Tahir Kurtuluş Yoldaş4, Ülkü Dönmez1, Cihat Uzunköprü3, Ebru Alemdaroğlu2, Şule Bilen5, Ufuk Emre6, Şenay Özdolap7, Elif Tuncay8, Canan Yücesan8, Haydar Gök9, Merve Bahar Ercan10, Kürşat Uygunol11, Belgin Koçer10, Murat Zinnuroğlu11.   

Abstract

OBJECTIVE: To determine the frequency and severity as well as the diagnosis and treatment of overactive bladder problems in patients with multiple sclerosis (MS) followed up at five centers in Turkey.
DESIGN: Survey study.
SETTING: Outpatient tertiary clinics of physical medicine and rehabilitation and neurology. PARTICIPANTS: Consecutive MS patients scheduled for outpatient follow-up (n = 309). INTERVENTION: MS patients were asked to complete a questionnaire regarding the frequency and severity, as well as the diagnosis and treatment of their overactive bladder problems.
RESULTS: The mean age ± SD was 39.3 ± 10.6 years. Urinary urgency was the most common urinary symptom (62%), followed by frequency (50.4%), urge incontinence (44.7%) and nocturia (33%). Residual urine volume was measured using a portable ultrasound instrument in 13.3% of the patients and by catheterization in 16.2% of them. Urodynamic investigations and urinary tract ultrasound were performed on 26.5% and 35.3% of the patients, respectively. Anticholinergic medications were prescribed for 27.5% of the patients. Intermittent catheterization and indwelling catheterization were used on 8.1% and 1.9% of the patients, respectively. The overactive bladder symptom score (OABSS) was significantly higher in patients who had had residual urine measurement (P < 0.001), upper urinary tract assessment by ultrasound (P < 0.001), urodynamic assessment (P < 0.001), admitted to a doctor for urinary symptoms (P < 0.001), and current or past catheter use (P = 0.002).
CONCLUSION: Urgency was the most common urinary symptom followed by frequency, urge incontinence and nocturia in MS patients. The patients with lower OABSS had detailed urological assessments less frequently than the patients with higher OABSS.

Entities:  

Keywords:  Indwelling catheterization; Intermittent catheterization; Multiple sclerosis; Neurogenic bladder; Urinary symptom

Mesh:

Year:  2016        PMID: 25936385      PMCID: PMC5072493          DOI: 10.1179/2045772315Y.0000000021

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  15 in total

1.  Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: analysis of risk factors at initial urologic evaluation.

Authors:  Gary E Lemack; Kathleen Hawker; Elliot Frohman
Journal:  Urology       Date:  2005-05       Impact factor: 2.649

Review 2.  Bladder symptoms in multiple sclerosis: a review of pathophysiology and management.

Authors:  Richard Nicholas; Carolyn Young; Tim Friede
Journal:  Expert Opin Drug Saf       Date:  2010-11       Impact factor: 4.250

3.  Under treatment of overactive bladder symptoms in patients with multiple sclerosis: an ancillary analysis of the NARCOMS Patient Registry.

Authors:  S T Mahajan; P B Patel; R A Marrie
Journal:  J Urol       Date:  2010-02-20       Impact factor: 7.450

4.  Long-term effect on quality of life of repeat detrusor injections of botulinum neurotoxin-A for detrusor overactivity in patients with multiple sclerosis.

Authors:  Shahid Khan; Xavier Game; Vinay Kalsi; Gwen Gonzales; Jalesh Panicker; Sohier Elneil; Apostolos Apostolidis; Rizwan Hamid; Prokar Dasgupta; Thomas M Kessler; Clare J Fowler
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

5.  Prevalence of bladder, bowel and sexual problems among multiple sclerosis patients two to five years after diagnosis.

Authors:  M W Nortvedt; T Riise; J Frugård; J Mohn; A Bakke; A B Skår; H Nyland; S B Glad; K M Myhr
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

Review 6.  Contemporary management of the neurogenic bladder for multiple sclerosis patients.

Authors:  John T Stoffel
Journal:  Urol Clin North Am       Date:  2010-11       Impact factor: 2.241

7.  Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.

Authors:  Sophie G Fletcher; Benjamin E Dillon; Alienor S Gilchrist; Rashel M Haverkorn; Jingsheng Yan; Elliot M Frohman; Gary E Lemack
Journal:  Mult Scler       Date:  2013-01-21       Impact factor: 6.312

Review 8.  The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines.

Authors:  Marianne de Sèze; Alain Ruffion; Pierre Denys; Pierre-Alain Joseph; Brigitte Perrouin-Verbe
Journal:  Mult Scler       Date:  2007-03-15       Impact factor: 6.312

Review 9.  A UK consensus on the management of the bladder in multiple sclerosis.

Authors:  C J Fowler; J N Panicker; M Drake; C Harris; S C W Harrison; M Kirby; M Lucas; N Macleod; J Mangnall; A North; B Porter; S Reid; N Russell; K Watkiss; M Wells
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-05       Impact factor: 10.154

Review 10.  Management of lower urinary tract dysfunction in multiple sclerosis: a systematic review and Turkish consensus report.

Authors:  Bülent Çetinel; Tufan Tarcan; Oktay Demirkesen; Ceyhun Özyurt; İlker Şen; Sarper Erdoğan; Aksel Siva
Journal:  Neurourol Urodyn       Date:  2013-06-11       Impact factor: 2.696

View more
  6 in total

1.  Nocturia in Patients With Multiple Sclerosis.

Authors:  Benoit Peyronnet; Lauren B Krupp; W Stuart Reynolds; Xavier Gamé; Gérard Amarenco; Jean-Nicolas Cornu; Lana Zhovtis Ryerson; Carrie Lyn Sammarco; Jonathan E Howard; Robert W Charlson; Roger R Dmochowski; Benjamin M Brucker
Journal:  Rev Urol       Date:  2019

Review 2.  Animal modeling of lower urinary tract dysfunction associated with multiple sclerosis: Part I: Justification of the mouse model for MS research.

Authors:  Ramalakshmi Ramasamy; Phillip P Smith
Journal:  Neurourol Urodyn       Date:  2021-03-14       Impact factor: 2.696

3.  Lower urinary tract symptoms and sexual dysfunction in men with multiple sclerosis.

Authors:  André Luiz Farinhas Tomé; Eduardo P Miranda; José de Bessa Júnior; Carlos Alberto Bezerra; Antônio Carlos Lima Pompeo; Sidney Glina; Cristiano Mendes Gomes
Journal:  Clinics (Sao Paulo)       Date:  2019-03-14       Impact factor: 2.365

4.  Bladder Dysfunction in Iranian Patients with Multiple Sclerosis.

Authors:  Mohaddeseh Azadvari; Seyede Zahra Emami Razavi; Masumeh Shahrooei; Abdorreza Naser Moghadasi; Amirreza Azimi; Hamid Reza Farhadi-Shabestari
Journal:  J Multidiscip Healthc       Date:  2020-04-02

5.  Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis.

Authors:  Hawra B Al Dandan; Susan Coote; Doreen McClurg
Journal:  Int J MS Care       Date:  2020 Mar-Apr

Review 6.  Overactive Bladder Symptoms Within Nervous System: A Focus on Etiology.

Authors:  Chuying Qin; Yinhuai Wang; Yunliang Gao
Journal:  Front Physiol       Date:  2021-12-10       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.